---
category: news
title: "Insilico Medicine receives IND approval for novel AI-designed USP1 inhibitor for cancer"
excerpt: "Insilico Medicine, a generative artificial intelligence-driven clinical stage drug discovery company, today announced that the U.S. Food and Drug Administration (FDA) recently approved the initial investigational new drug (IND) application for ISM3091 for the treatment of patients with solid tumors."
publishedDateTime: 2023-05-25T00:00:00Z
originalUrl: "https://www.eurekalert.org/news-releases/990417"
webUrl: "https://www.eurekalert.org/news-releases/990417"
type: article

provider:
  name: EurekAlert!
  domain: eurekalert.org

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://earimediaprodweb.azurewebsites.net/Api/v1/Multimedia/2a412290-7ed2-4760-b074-699493cca957/Rendition/low-res/Content/Public"
    width: 700
    height: 368
    isCached: true

secured: "Yf25pr3oqfVa5ORD3TGT5POX2ctHL6l6XrGVn517hK7kCbAcU9bUE1aqOoswUJV4lZV5yGWr3qU+84jshZUa1xiGDdVkesNc8+7laLcaVKaNGK3duaMCfggmEIZH9decVb2FXdO/TOmgDZc1q4y4qqTc5RqRWJ/OqPYre+b1jU7Pod70d48nBK7SUvyDsS7hQ8dOMCfJiWotjSwYwHiUIqz8v500PIElPR0/nfp9288qk46vfYgQeqhKRc4aGjnMZYQvRwOTrcmv4Jgm8XeeKAQVGy+6i8ELjQjvcXCnrPdSOylmUcIQQniTbiWb5Vs5BoPi0EVt2X2PN7VHiGmrE0C9Q6+yJxGJzHKp2C8UMWA=;HTPiv5G9N7QJOECeL+YXyw=="
---

